Financing the French supreme healthcare authority:
This article was originally published in Clinica
The French health ministry has published a decree outlining the contributions that healthcare facilities must make towards the running costs of the new supreme healthcare authority, the HAS. The rates are linked to the number of beds or consulting rooms the facility has. The decree was published in the Journal officiel of November 30 2004.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.